Skye Bioscience SKYE
NASDAQ SKYE
$1.54 -0.08 (-4.94%)
At close: Oct 23, 2026 · 4:00 PM EDT

Skye Bioscience (SKYE) Net of Acquisitions & Divestments (2022 - 2025)

Updated

Analysis

Skye Bioscience (SKYE) Net of Acquisitions & Divestments (2022 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Acquisitions (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -8.75 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 17.15 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn -
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 39.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -11.21 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn -
10 Skye Bioscience 6.77 Mn -81.46 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 179,987.00
Sep 30, 2025 91,400.00
Jun 30, 2025 89,363.00
Dec 31, 2024 140,434.00
Sep 30, 2024 72,837.00
Mar 31, 2024 1.15 Mn
Dec 31, 2022 5.31 Mn
API Access

Skye Bioscience Net of Acquisitions & Divestments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-of-acquisitions-and-divestments&ticker=SKYE&period=max&api_key=YOUR_API_KEY